Korro Bio, Inc. (KRRO)
NASDAQ·Healthcare·Biotechnology
$9.90
-4.26%
Mkt Cap $115.83M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$20.00
Range $15.00 – $23.00
Implied Upside
+102.0%
Consensus $20.00 vs current $9.90
NASDAQ·Healthcare·Biotechnology
$9.90
-4.26%
Mkt Cap $115.83M
No recent rating data.
Price Target (15 analysts)
$20.00
Range $15.00 – $23.00
+102.0%
Consensus $20.00 vs current $9.90